BCL2 and cancer: The cytotoxic activity of 28 was evaluated against several cancer cells and caused the induction of cell cycle arrest at the G2/M phase, the activation of caspase-3 and -9, an increase in BAX, and a concomitant reduction in BCL-2 (mediated by p53).